Vitamin e prevents hyperoxia-induced loss of soluble n-ethylmaleimide- sensitive fusion protein attachment protein receptor proteins in the rat neuronal cytoplasm

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 9, 2013, Pages 1500-1502

  Kaneai, Nozomi ^a   Fukui, Koji ^a   Koike, Taisuke ^b   Urano, Shiro ^a  

^a SHIBAURA INSTITUTE OF TECHNOLOGY   (Japan)

^b EISAI CO LTD   (Japan)

Author keywords

Membrane fusion; N ethylmaleimide sensitive fusion protein attachment protein receptor; Neurodegeneration; Neurotransmission; Vitamin e

Indexed keywords

ALPHA TOCOPHEROL; N ETHYLMALEIMIDE SENSITIVE FACTOR; SNARE PROTEIN; SOLUBLE N ETHYLMALEIMIDE SENSITIVE FACTOR ATTACHMENT PROTEIN; SOLUBLE N ETHYLMALEIMIDE SENSITIVE FACTOR ATTACHMENT PROTEIN ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN NERVE CELL; CELL FUNCTION; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; FOOD COMPOSITION; HYPEROXIA; MALE; MEMBRANE FUSION; MOLECULAR DOCKING; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; SYNAPSE VESICLE; SYNAPTOSOME; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; BRAIN; CYTOPLASM; HYPEROXIA; MALE; N-ETHYLMALEIMIDE-SENSITIVE PROTEINS; OXIDATIVE STRESS; RATS; RATS, WISTAR; SNARE PROTEINS; SOLUBLE N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEINS; SYNAPTOSOMES; VITAMIN E;

EID: 84884624048     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00147     Document Type: Article

References (11)

1. Katzman R. Alzheimer's disease. N. Engl. J. Med., 314, 964-973 (1986).
2. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR. Evidence of increased oxidative damage in subject with mild cognitive impairment. Neurology, 64, 1152-1156 (2005).
3. Urano S, Asai Y, Makabe S, Matsuo M, Izumiyama N, Ohtsubo K, Endo T. Oxidative injury of synapse and alteration of antioxidative defense systems in rats, and its prevention by vitamin E. Eur. J. Biochem., 245, 64-70 (1997).
4. Fukui K, Omoi NO, Hayasaka T, Shinnkai T, Suzuki S, Abe K, Urano S. Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann. N. Y. Acad. Sci., 959, 275-284 (2002).
5. Lin RC, Sheller RH. Structural organization of the synaptic exocytosis core complex. Neuron, 19, 1087-1094 (1997).
6. Kaneai N, Arai M, Takatsu H, Fukui K, Urano S. Vitamin E inhibits oxidative stress-induced denaturation of nerve terminal proteins involved in neurotransmission. J. Alzheimers Dis., 28, 183-189 (2012).
7. Dodd PR, Hardy JA, Oakley AE, Edwardson JA, Perry EK, Delaunoy JP. A rapid method for preparing synaptosomes: Comparison with alternative procedures. Brain Res., 226, 107-118 (1981).
8. Urano S, Sato Y, Otonari T, Makabe S, Suzuki S, Ogata M, Endo T. Aging and oxidative stress in neurodegeneration. Biofactors, 7, 103-112 (1998).
9. Shimohama S, Kamiya S, Taniguchi T, Akagawa K, Kimura J. Differential involvement of synaptic vesicle and pre-synaptic plasma membrane proteins in Alzheimer's disease. Biochem. Biophys. Res. Commun., 236, 239-242 (1997).
10. Shimohama S, Fujimoto S, Sumida Y, Akagawa K, Shirao T, Matsuoka Y, Taniguchi T. Differential expression of rat brain synaptic proteins in development and aging. Biochem. Biophys. Res. Commun., 251, 394-398 (1998).
11. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N. Engl. J. Med., 336, 1216-1222 (1997).